Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Non Operating Income (2016 - 2017)

Historic Non Operating Income for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to -$1.5 million.

  • Bone Biologics' Non Operating Income rose 792.31% to -$1.5 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$4.4 million, marking a year-over-year increase of 1904.73%. This contributed to the annual value of -$507609.0 for FY2021, which is 4914.12% up from last year.
  • As of Q4 2017, Bone Biologics' Non Operating Income stood at -$1.5 million, which was up 792.31% from -$1.2 million recorded in Q3 2017.
  • Bone Biologics' 5-year Non Operating Income high stood at -$359908.0 for Q2 2016, and its period low was -$3.2 million during Q1 2016.